Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Audit finds high levels of hidden ketosis
30 per cent of newly calved cows in state of subclinical ketosis

In a recent audit of UK dairy herds, it was found that the prevalence of subclinical or 'hidden' ketosis averaged 30 per cent in newly calved cows. Levels in individual herds varied from 10 to 60 per cent. These cows were not only found to be more likely to develop clinical ketosis, but were also at greater risk of developing other metabolic and reproductive disorders such as retained placenta, displaced abomasum and milk fever.

763 cows from 15 dairy herds were tested in the UK farm audits. Ketosis was determined by measuring beta-hydroxbutyrate (BHBA) levels in the milk of cows which had calved 7 to 21 days previously. Levels were measured using the cow-side diagnostic Keto-Test, and a positive diagnosis was given when BHBA levels exceeded 100mol/litre. The cows were also observed during the first 35 days of lactation, not only to see if clinical ketosis developed, but also to monitor other potential health problems that may arise.

The study was also conducted across four other European countries - Germany, France, Italy and The Netherlands, testing a total of 2,489 cows. The audit revealed that cows testing positive for hidden ketosis were 11.5 times more likely to progress to clinical ketosis. They were also 1.7 times more likely to have a difficult calving, 2.2 times more likely to have had a retained placenta and 1.8 times more likely to have had milk fever.

Other results suggested these animals were 4.5 times more likely to suffer gastrointestinal distress, 2.3 times more likely to get mastitis and 2.7 times more likely to get a displaced abomasum. The audit additionally found a small but significant trend indicating an increased susceptibility to metritis.

Technical consultant for Elanco Mike Steele said: "Clinical ketosis was diagnosed in 1 per cent of cows surveyed in the main audit. This is in line with previous findings. It highlights that whilst clinical cases of ketosis are rare, these cases are just 'the tip of the iceberg' and a much larger number of animals will be experiencing subclinical levels of ketosis.

"These may develop into clinical ketosis and/or other clinical disease, as the survey demonstrated."

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.